SEC Form D · filed February 5, 2024
RedHill Biopharma Ltd
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (36)
Susan C. Schnabel · New York, NYExecBrian C. Power · VACAVILLE, CADirectorGaurav Gambhir · Philadelphia, PADirectorJeffrey N. Vale · Atlanta, GAExecJosh S. Stein · Palo Alto, CADirectorDror Ben-Asher · Tel Aviv, L3Exec · DirectorJoshua E. Wyss · Mill Valley, CADirectorKenneth Reed · Tel Aviv, L3DirectorIngrid Mulder · Amstelveen, P7Exec · DirectorShmuel Cabilly · Tel Aviv, L3DirectorRazi Ingber · Tel Aviv, L3ExecOfer Tsimchi · Tel Aviv, L3DirectorBrandon Contino · Turtle Creek, PAExecReza D. Fathi · Tel Aviv, L3ExecAldo Zini · Turtle Creek, PADirectorEric Swenden · Tel Aviv, L3DirectorAdi D. Frish · Tel Aviv, L3ExecJacob S. Horne · SAN FRANCISCO, CAExecJohn C. Power · VACAVILLE, CAExec · DirectorMohamed Arafa · Amstelveen, P7DirectorKen Johnson · Franklin, MIDirectorRick D. Scruggs · Tel Aviv, L3Exec · DirectorPeter R. Kagan · Tulsa, OKExecDarren O'Brien · WAN CHAI, Hong KongDirectorBruce W. Snyder · Seattle, WAExec · DirectorAlla D. Felder · Tel Aviv, L3DirectorSteven A. Anderson · SOUTH PASADENA, CADirectorDavid Meredith · NEWPORT BEACH, CAExecRazi Ingber · Tel Aviv, L3ExecGilead D. Raday · Tel Aviv, L3ExecCleon N. Daskalakis · Boston, MAExecDouglas Buchalter · Asheville, NCExecGuy D. Goldberg · Tel Aviv, L3ExecSimone Blank · NEWPORT BEACH, CAExec · DirectorJost Fischer · NEWPORT BEACH, CADirectorRick Taketa · CORONA DEL MAR, CAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗